Palantir Technologies shares saw a significant jump after strong financial forecasts were released. The company raised its full-year revenue and income projections considerably for this year. US commercial sales experienced a substantial increase, which boosted investor confidence. This performance helped alleviate concerns about competition from AI developers. The company's stock experienced its largest intraday gain in over a year.

Palantir (PLTR) stock rises premarket ahead of Q2 earnings while facing new NHS contract scrutiny over its data platform.

Palantir Technologies stock has fallen over 40% from its November 2025 peak of $207.52 despite strong revenue growth exceeding 70%